Entity Details

Primary name CASR
Entity type gene
Source Source Link

Details

PrimaryID846
RefseqGeneNG_009058
SymbolCASR
Namecalcium sensing receptor
Chromosome3
Location3q13.33-q21.1
TaxID9606
Statuslive
SourceGenomegenomic
SourceOriginnatural
CreationDate1998-08-12
ModificationDate2021-06-22

Ontological Relatives

UniProt IDsCASR_HUMAN

GO terms

Show/Hide Table
GOName
GO:0001503 ossification
GO:0002931 response to ischemia
GO:0004435 phosphatidylinositol phospholipase C activity
GO:0004930 G protein-coupled receptor activity
GO:0005178 integrin binding
GO:0005509 calcium ion binding
GO:0005513 detection of calcium ion
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0006874 cellular calcium ion homeostasis
GO:0006915 apoptotic process
GO:0007186 G protein-coupled receptor signaling pathway
GO:0007193 adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway
GO:0007254 JNK cascade
GO:0007635 chemosensory behavior
GO:0008284 positive regulation of cell population proliferation
GO:0009653 anatomical structure morphogenesis
GO:0009986 cell surface
GO:0010628 positive regulation of gene expression
GO:0016323 basolateral plasma membrane
GO:0016324 apical plasma membrane
GO:0016597 amino acid binding
GO:0019901 protein kinase binding
GO:0032024 positive regulation of insulin secretion
GO:0032781 positive regulation of ATPase activity
GO:0032782 bile acid secretion
GO:0035729 cellular response to hepatocyte growth factor stimulus
GO:0042311 vasodilation
GO:0042803 protein homodimerization activity
GO:0043025 neuronal cell body
GO:0043679 axon terminus
GO:0044325 transmembrane transporter binding
GO:0045907 positive regulation of vasoconstriction
GO:0048754 branching morphogenesis of an epithelial tube
GO:0050927 positive regulation of positive chemotaxis
GO:0051924 regulation of calcium ion transport
GO:0060613 fat pad development
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0070509 calcium ion import
GO:0071305 cellular response to vitamin D
GO:0071333 cellular response to glucose stimulus
GO:0071404 cellular response to low-density lipoprotein particle stimulus
GO:0071456 cellular response to hypoxia
GO:0071774 response to fibroblast growth factor
GO:0090280 positive regulation of calcium ion import
GO:1901653 cellular response to peptide
GO:1902476 chloride transmembrane transport

Diseases

Show/Hide Table
Disease IDSourceNameDescription
145980 OMIMHypocalciuric hypercalcemia, familial 1 (HHC1)A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults. The disease is caused by variants affecting the gene represented in this entry.
601198 OMIMHypocalcemia, autosomal dominant 1 (HYPOC1)A disorder of mineral homeostasis characterized by blood calcium levels below normal, and low or normal serum parathyroid hormone concentrations. Disease manifestations include mild or asymptomatic hypocalcemia, paresthesias, carpopedal spasm, seizures, hypercalciuria with nephrocalcinosis or kidney stones, and ectopic and basal ganglia calcifications. Few patients manifest hypocalcemia and features of Bartter syndrome, including hypomagnesemia, hypokalemia, metabolic alkalosis, hyperreninemia, and hyperaldosteronemia. The disease is caused by variants affecting the gene represented in this entry.
239200 OMIMHyperparathyroidism, neonatal severe (NSHPT)A disorder characterized by severe hypercalcemia, bone demineralization, and failure to thrive usually manifesting in the first 6 months of life. If untreated, NSHPT can be a devastating neurodevelopmental disorder, which in some cases is lethal without parathyroidectomy. The disease is caused by variants affecting the gene represented in this entry.
612899 OMIMEpilepsy, idiopathic generalized 8 (EIG8)A disorder characterized by recurring generalized seizures in the absence of detectable brain lesions and/or metabolic abnormalities. Seizure types are variable, but include myoclonic seizures, absence seizures, febrile seizures, complex partial seizures, and generalized tonic-clonic seizures. Disease susceptibility is associated with variants affecting the gene represented in this entry.